NYSEAMERICAN:PFNX

Pfenex (PFNX) Stock Price, News & Analysis

Pfenex logo
$12.75 0.00 (0.00%)
As of 10/1/2020

About Pfenex Stock (NYSEAMERICAN:PFNX)

Key Stats

Today's Range
$12.75
▼
$12.75
50-Day Range
$12.75
▼
$12.75
52-Week Range
$5.26
▼
$14.00
Volume
N/A
Average Volume
503,865 shs
Market Capitalization
$437.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pfenex was a biotechnology company that developed recombinant proteins and biosimilar medicines using its Pfenex Expression Technology platform. Its work focused on producing complex proteins for pharmaceutical applications.

The company advanced PF708, a teriparatide injection later marketed as Bonsity, and collaborated with Pfizer on PF-06439535, a bevacizumab biosimilar marketed as Zirabev. These products were developed for markets including the United States and other countries through commercial partnerships.

Based in San Diego, California, Pfenex became part of Ligand Pharmaceuticals after Ligand completed its acquisition of the company in 2020.

AI Generated. May Contain Errors.

Receive PFNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pfenex and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PFNX Stock News Headlines

NKY Medical Holdings Ltd Class A 300109
Your Social Security check is scheduled for a 22% cut
The U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt death spiral. Interest payments alone now top a trillion dollars a year. The Social Security trust fund is projected to run dry by 2032, which could trigger an automatic 22% cut to benefits. Between 2020 and 2022, the Fed expanded the money supply by 41%. A free 27 page report breaks down these numbers in plain English, including what central banks have been doing with gold.tc pixel
See More Headlines

PFNX Stock Analysis - Frequently Asked Questions

Pfenex's stock was trading at $12.75 at the beginning of 2026. Since then, PFNX shares have increased by 0.0% and is now trading at $12.75.

Pfenex Inc. (NYSEAMERICAN:PFNX) released its quarterly earnings data on Thursday, May, 7th. The biotechnology company reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.24) by $0.07. The biotechnology company had revenue of $680 thousand for the quarter, compared to analysts' expectations of $3.75 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pfenex investors own include Inovio Pharmaceuticals (INO), Alibaba Group (BABA), Bank of America (BAC), Anheuser-Busch InBev SA/NV (BUD), Salesforce (CRM), Applied Materials (AMAT) and Advanced Micro Devices (AMD).

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NYSEAMERICAN:PFNX
Previous Symbol
NYSEMKT:PFNX
CIK
N/A
Fax
N/A
Employees
71
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
34,297,000
Free Float
N/A
Market Cap
$437.29 million
Optionable
Not Optionable
Beta
N/A
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NYSEAMERICAN:PFNX) was last updated on 10/1/2020 by MarketBeat.com Staff.
From Our Partners